Skip Nav Destination
1-9 of 9
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma
Elizabeth B Lamont, MD MS, MMSc, Andrew J. Yee, MD, Stuart L. Goldberg, MD, Andrew D Norden, MD MPH, MBA
Blood (2019) 134 (Supplement_1): 2193.
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation
Ankur Varma, MD, Neeraj Y Saini, MD, Dawen Sui, Denái R. Milton, Omar Hasan, Akash Mukherjee, MD, Qaiser Bashir, MD MBBS, Gabriela Rondon, MD, Samer A. Srour, MD, Uday Popat, MD, Chitra Hosing, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MD MPH, MS, Issa F. Khouri, Donna M. Weber, MD, Sheeba K. Thomas, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Krina K. Patel, MD MSc, Stefan O. Ciurea, Elizabeth J. Shpall, MD, Robert Z Orlowski, MD PhD, Richard E Champlin, MD, Muzaffar H. Qazilbash, MD
Blood (2018) 132 (Supplement 1): 4609.
Katherine Tarlock, MD, Yuting He, James Sun, Rhonda E. Ries, MA, Eric A Severson, MD PhD MMSc, Mark Bailey, MS, Samantha Morley, PhD, Sohail Balasubramanian, Rachel Erlich, PhD, Doron Lipson, PhD, Geoff Otto, PhD, Jo-Anne Vergillo, Jeffrey S Ross, MD, Tariq Mughal, FRCP, Phil Stephens, PhD, Vincent Miller, MD, Soheil Meshinchi, MD PhD, Jie He, PhD
Blood (2017) 130 (Supplement 1): 3800.
CD46 Is Amplified in High-Risk Myeloma with Gain of Chromosome 1q and Selectively Targeted By a Novel Anti-CD46 Antibody-Drug Conjugate
Daniel W. Sherbenou, MD PhD, Blake T. Aftab, PhD, Yang Su, PhD, Christopher R. Behrens, PhD, Arun P. Wiita, MD PhD, Aaron C. Logan, MD PhD, Diego Acosta-Alvear, PhD, Byron C. Hann, MD PhD, Peter Walter, PhD, Xiaobo Wu, MD, John P. Atkinson, MD, Jeffrey L. Wolf, MD, Thomas G. Martin, III, MD, Bin Liu, PhD
Blood (2016) 128 (22): 384.
Frequent Chromosome 1q Aberrations in HIV Associated B-Cell Lymphoma Unclassifiable with Intermediate Features Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma,
Blood (2011) 118 (21): 3572.
Integrative Analysis of Genomic Aberration and Gene Expression Suggests That MPD with Loss of Heterozygosity or Gain of Chromosome 9 Represents a Distinct Entity
Weijia Zhang, PhD, Benjamin L. Ebert, MD, DPhil, Windy Berkofsky-Fessler, PhD, Monica Buzzai, PhD, Yezhou Sun, MSc, Caixia Xi, MSc, Ross L Levine, MD, D. Gary Gilliland, MD, PhD, Jonathan D. Licht, MD
Blood (2008) 112 (11): 3735.
CD32B on Clonal Plasma Cells in Systemic Light-Chain Amyloidosis (AL) and Multiple Myeloma (MM): A Target for Immunotherapy in Both Disorders and a Prognostic Marker in MM.
Adam Boruchov, MD, P. Zhou, MD, PhD, A. Olshen, PhD, C. Rankin, E. Bonvini, MD, S. Koenig, MD, PhD, M. Fleisher, PhD, R. Rose, S. McKenzie, Peter Maslak, MD, Suresh C. Jhanwar, PhD, James W. Young, MD, Stephen D. Nimer, MD, Raymond Comenzo, MD
Blood (2006) 108 (11): 3489.
Jonathan S. Caudill, MD, Ruchira Sood, PhD, James L. Zehnder, MD, Erik C. Thorland, PhD, Vilmarie Rodriguez, MD, Rajiv K. Pruthi, MD, David P. Steensma, MD
Blood (2006) 108 (11): 1043.
Jumping Translocations of Chromosome 1q in Multiple Myeloma: Evidence for a Mechanism Involving Decondensation of Pericentromeric Heterochromatin
Blood (1998) 91 (5): 1732–1741.